InsidersTradesSigma
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (2 ops.)
Insider track record
CEODisclosed buys
1
Disclosed sells
2
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the complete record of transactions filed by Schadt Eric, Chairman & CEO. Officer active across 1 company, notably Sema4 Holdings Corp.. Aggregated, 7 reports have been logged. Split: 1 buy · 2 sells. Total volume traded: €331k. Activity tracked since 1 December 2021. The latest transaction was disclosed on 20 May 2022 (Acquisition). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations7 total
100,000 shares@ US$1.924835.0% of flowClass A Common StockSEC:0001209191-22-031764:0
Ideal exit: 14 Feb 2023 (T+270)
35,899 shares@ US$2.180414.3% of flowClass A Common StockSEC:0001209191-22-026493:0
78,812 sharesClass A Common StockSEC:0001209191-22-025888:0
29,100 shares@ US$2.840814.3% of flowClass A Common StockSEC:0001209191-22-006609:0
78,812 sharesClass A Common StockSEC:0001209191-22-005286:0
10,727 shares@ US$6.0511.0% of flowClass A Common StockSEC:0001209191-21-067985:0
78,812 sharesClass A Common StockSEC:0001209191-21-062548:0
7 of 7 declarations
About Schadt Eric
Eric Schadt is the Chairman & CEO and Chief R&D Officer of Sema4 Holdings Corp. He leads the company with a focus on innovation and research, aiming to enhance healthcare solutions. Eric plays a key role in developing new technologies and services for the industry.
